US Stock MarketDetailed Quotes
MCRB Seres Therapeutics
- 0.837
- -0.065-7.21%
Close Oct 3 16:00 ET
127.57MMarket Cap-703P/E (TTM)
0.900High0.837Low3.34MVolume0.850Open0.902Pre Close2.86MTurnover2.76%Turnover RatioLossP/E (Static)152.38MShares2.05052wk High-1.47P/B101.17MFloat Cap0.54052wk Low--Dividend TTM120.85MShs Float52.000Historical High--Div YieldTTM6.94%Amplitude0.540Historical Low0.857Avg Price1Lot Size
Seres Therapeutics Stock Forum
Sign in to post a comment
$Seres Therapeutics (MCRB.US)$ IM BACK FOR MORE MONEY!!! 10k @ $0.847 FUCK YOU PAY ME 🖕🖕🖕
1
$Seres Therapeutics (MCRB.US)$
Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A
Seres Therapeutics (Nasdaq: MCRB) has completed the sale of its VOWST business to Nestlé Health Science, strengthening its financial position and focusing on developing novel live biotherapeutics for high-risk patient populations.
The transaction provides $175M in gross proceeds, with additional future payments expected. This extends Seres' cash runway into Q4 2025.
...
Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A
Seres Therapeutics (Nasdaq: MCRB) has completed the sale of its VOWST business to Nestlé Health Science, strengthening its financial position and focusing on developing novel live biotherapeutics for high-risk patient populations.
The transaction provides $175M in gross proceeds, with additional future payments expected. This extends Seres' cash runway into Q4 2025.
...
3
1
well done 
$Seres Therapeutics (MCRB.US)$ Reuters
1 min ago
Seres Therapeutics Stockholders Approve Sale of Vowst™ to Nestlé Health Science; Sale Expected to Close on September 30
1 min ago
Seres Therapeutics Stockholders Approve Sale of Vowst™ to Nestlé Health Science; Sale Expected to Close on September 30
2
$Seres Therapeutics (MCRB.US)$
Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30
Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30
$Seres Therapeutics (MCRB.US)$
Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)
Seres Therapeutics (Nasdaq: MCRB) reports positive results from the Phase 1b placebo-controlled study of SER-155 in patients undergoing allogeneic hematopoietic stem cell transplant (allo-HSCT). The study showed:
Significant reduction in bacterial bloodstream infections (BSIs) a...
Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)
Seres Therapeutics (Nasdaq: MCRB) reports positive results from the Phase 1b placebo-controlled study of SER-155 in patients undergoing allogeneic hematopoietic stem cell transplant (allo-HSCT). The study showed:
Significant reduction in bacterial bloodstream infections (BSIs) a...
$Seres Therapeutics (MCRB.US)$ Reuters· 2 mins ago
Seres Therapeutics Inc - to Receive $175M Cash Infusion
to Fully Retire Debt
Seres: Potential for Additional Future Commercial Milestone Payments of up to $275M From Vowst Sales Targets
plus additional 75 million in 2025
Seres Therapeutics Inc - to Receive $175M Cash Infusion
to Fully Retire Debt
Seres: Potential for Additional Future Commercial Milestone Payments of up to $275M From Vowst Sales Targets
plus additional 75 million in 2025
2
2
Follow Our Official Telegram Channel tynkrlab
$Dow Jones Industrial Average (.DJI.US)$ rose by 0.59% to a new record high, closing at 41,211.12. In contrast, the $S&P 500 Index (.SPX.US)$ fell by 1.39%, and the $Nasdaq Composite Index (.IXIC.US)$ dropped by 2.76%. Tech stocks faced significant pressure, contributing to the mixed market performance.
Key Drivers
1. Strong Performers: $UnitedHealth (UNH.US)$, $Johnson & Johnson (JNJ.US)$, and $Cisco (CSCO.US)$ l...
$Dow Jones Industrial Average (.DJI.US)$ rose by 0.59% to a new record high, closing at 41,211.12. In contrast, the $S&P 500 Index (.SPX.US)$ fell by 1.39%, and the $Nasdaq Composite Index (.IXIC.US)$ dropped by 2.76%. Tech stocks faced significant pressure, contributing to the mixed market performance.
Key Drivers
1. Strong Performers: $UnitedHealth (UNH.US)$, $Johnson & Johnson (JNJ.US)$, and $Cisco (CSCO.US)$ l...
6
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
The Real Wojak OP : Fucking piece of shit